Letter by mead et al regarding article, "selective serotonin reuptake inhibitors for stroke: More trials are needed"

Stroke

Volumn 44, Issue 4, 2013, Pages

  Mead, Gillian E ^a   Dennis, Martin ^a   Lundström, Erik ^b   Murray, Veronica ^c   Hackett, Maree ^d   Hankey, Graeme J ^e  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c DANDERYD HOSPITAL   (Sweden)

^d GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^e ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE;

ANXIETY DISORDER; CEREBROVASCULAR ACCIDENT; DEPRESSION; HUMAN; LETTER; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); UNSPECIFIED SIDE EFFECT;

HUMANS; SEROTONIN UPTAKE INHIBITORS; STROKE;

EID: 84876298283     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.112.681130     Document Type: Letter

References (5)

1. Chollet F. Selective serotonin reuptake inhibitors may be helpful in most patients with stroke. Stroke. 2012;43:3150-3151.
2. Marshall RS. Should every patient with stroke be on selective serotonin reuptake inhibitors? No. Stroke. 2012;43:3152-3153.
3. Chollet F, Tardy J, Albucher J-F, Thalamas C, Berard E, Lamy C, et al. Fluoxetine for motor recovery after acute ischaemic stroke (FLAME): a randomised placebo-controlled trial. Lancet Neurol 2011;10:123-130.
4. Selim MH, Molina CA. Post-stroke treatment with selective serotonin reuptake inhibitors: a journey from sadness to motor recovery. Stroke. 2012; 43:3154-3155.
5. Mead GE, Hsieh C-F, Lee R, Kutlubaev M, Claxton A, Hankey G, et al. Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database Syst Rev. 2012;11:CD009286.